Rafaela Kramer

Statistics

Publications

Citations

366

H-Index

Active since

2021

Affiliations

Universitätsklinikum Erlangen(Current)

Ludwig-Maximilians-Universität München

Comprehensive Cancer Center Erlangen

Friedrich-Alexander-Universität Erlangen-Nürnberg

Heinrich Heine University Düsseldorf

Rafaela Kramer is an author at Universitätsklinikum Erlangen specializing in oncology, immune-related adverse events, and immune-mediated adverse events.

ORCID

Publications per year

2021–2024

Publications

Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors

Nicolás Gonzalo Núñez, Fiamma Berner, Ekaterina Friebel et al. · Med · 2023 · 122 citations · Full text

Life Sciences, Immunology, Oncology +17

Hematological immune related adverse events after treatment with immune checkpoint inhibitors

Rafaela Kramer, Anne Zaremba, Alvaro Moreira et al. · European Journal of Cancer · 2021 · 94 citations

Medicine, Hematology, Oncology +14

Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors

Theresa Ruf, Rafaela Kramer, Andrea Forschner et al. · European Journal of Cancer · 2024 · 47 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Ultraviolet Filters: Dissecting Current Facts and Myths

Thomas Breakell, Isabel Kowalski, Yannick Foerster et al. · Journal of Clinical Medicine · 2024 · 33 citations · Full text

Public Health, Dermatology, Toxicology +17

Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis

Anne Zaremba, Rafaela Kramer, Viola De Temple et al. · Frontiers in Oncology · 2021 · 19 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 9